Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT)

Bone Marrow Transplantation

Volumn 20, Issue 1, 1997, Pages 67-69

  Toren, A ^a,b,c   Or, R ^a   Ackerstein, A ^a   Nagler, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autologous bone marrow transplantation; Immunotherapy; Invasive fungal infections

Indexed keywords

ADULT; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; DISEASE COURSE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; IMMUNOTHERAPY; LUNG MYCOSIS; LYMPHOMA; MALE; MUCORMYCOSIS; MYCOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0030811323     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700847     Document Type: Article

References (24)

1. Goodrich JM, Reed EC, Mon M et al. Clinical features and analysis of risk factors for innvasive candidal infection after marrow transplantation. J Infect Dis 1991; 164: 731-740.
2. Iwen P, Ameton MA, Reed EC. Nosocomial aspergillosis in lymphoma patients treated with BMT or peripheral stem cell transplants (PSCT). Am Soc Microbiol 21st General Meeting, 1991, p429.
3. Rohatiner AZ, Freedman A, Nadler L et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma. Ann Oncol 1994; 5 (Suppl. 2): 143-146.
4. Drakos PE, Nagler A, Or R et al. Invasive fungal sinusitis in patients undergoing marrow transplantation. Bone Marrow Transplant 1993; 12: 203-208.
5. Polacheck I, Nagler A, Okon E et al. Aspergillus quadrilineatus, a new causative agent of fungal sinusitis. J Clin Microbiol 1992; 30: 3290-3293.
6. Saah D, Drakos PE, Elidan J et al. Rhinocerebral aspergillosis in patients undergoing bone marrow transplantation. Ann Otol Laryngol 1994; 103: 306-309.
7. Walsh TJ, Lee J, Lecciones J et al. Empiric therapy with amphotericin B in febrile granulocytopenic patients. Infect Dis 1991; 13: 496-503.
8. Kolb HJ, Mittermuller J, Clemm CH et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogeneous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2467.
9. Nagler A, Morecki S, Ackerstein A et al. Experimental and clinical cellular immunotherapy in bone marrow transplantation. In: Morystyn C, Shreidan W (eds). Cell Therapy. Cambridge University Press: Cambridge, MA, USA, 1995, pp 527-549.
10. Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral lymphocytes. Exp Hematol 1995; 23: 1553-1562.
11. Nagler A, Drakos P, Ackerstein A et al. Autologous bone marrow transplantation for Hodgkin's lymphoma and Hodgkin's disease: the role of immunotherapy. Eur J Cancer 1993; 29A (Suppl.): S173.
12. Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195-2204.
13. Or R, Nagler A, Ackerstein A et al. Allogeneic cell-mediated cytokine-activated immunotherapy of non-Hodgkin lymphoma for eradication of minimal residual disease in conjunction with ABMT. Blood 1993; 82: 171a.
14. Slavin S, Naparstek E, Nagler A et al. Cell-mediated immunotherapy for the treatment of malignant hematological diseases in conjunction with autologous BMT. Blood 1993: 82: 322a.
15. Slavin S, Naparstek E, Nagler A et al. Immunotherapy of leukemia using allogeneic cell therapy and recombinant human IL-2 of relapse following allogeneic BMT. Blood 1995; 86: 565a.
16. Joshi JH, Schrimpff SC. Infections in the compromised host. In: Mandell CL, Douglas RG, Bennet JE (eds). Principles and Practice of Infectious Diseases, 2nd edn. John Wiley: New York, 1985, pp 1644-1649.
17. Masur H. Infections in the critically ill immunosuppressed patients. In: Parrillo JE, Masur H (eds). The Critically Ill Immunosuppressed Patient. Rockville: Aspen, 1987, pp 215-242.
18. Young RC, Bennet JE, Vogel CL et al. Aspergillosis: the spectrum of the disease in 98 patients. Medicine 1970, 49: 147-173.
19. Pfaffenbach B, Donhuijsen K, Pahnke J et al. Systemic fungal infections in hematologic neoplasms. An autopsy study of 1053 patients. Med-Klin 1994; 89: 299-304.
20. Lum LC. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69: 369-380.
21. Storb R, Thomas ED. Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev 1985, 88: 215-238.
22. Savary CA, Lotzova E. Inhibition of human bone marrow and myeloid progenitors by IL-2-activated lymphocytes. Exp Hematol 1990; 18: 1083-1089.
23. Syndman DR, Bernadaette S, Maura Gill RN et al. Nosocomial sepsis associated with interleukin-2. Ann Intern Med 1990; 112: 102-107.
24. Richards JM, Gilewski TA, Vogelzang NJ. Association of IL-2 therapy with staphylococcal bacteremia. Cancer 1991; 67: 1570-1575.